Janssen’s Balversa gets FDA approval for metastatic bladder cancer

This article was originally published here

Balversa is now indicated in the US for the treatment of adult patients having locally advanced or metastatic bladder cancer that has a type of susceptible genetic alteration

The post Janssen’s Balversa gets FDA approval for metastatic bladder cancer appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply